Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
Follicle stimulating hormone receptor (FSHR) belongs to class‑A G‑protein‑coupled receptor superfamily, encoded by the FSHR gene and predominantly presented as aseven‑transmembrane receptoron gonadal cell plasma surfaces. Its modular architecture comprises a large glycosylated extracellular leucine‑rich repeat ectodomain responsible for ligand capture, a seven‑pass transmembrane helix bundle forming the core signal‑transducing scaffold, plus an intracellular C‑terminal segment mediating cytoplasmic adaptor docking. The extended leucine‑rich ectodomain establishes extensive shape‑complementary contact surfaces for circulating glycoprotein ligand recognition, and ligand engagement triggers allosteric rearrangement within the transmembrane helical bundle that propagates conformational changes toward the cytoplasmic face. Sustained unbalanced receptor surface abundance disturbs downstream intracellular signal amplitudes, and variable receptor population densities at cell surfaces establish graded response thresholds rather than fixed signaling output. Gonadal cell populations tune FSHR membrane abundance in accordance with tissue physiological status; leucine‑rich repeat units collectively shape the ligand‑selective binding groove, and N‑linked glycan modifications distributed across the ectodomain contribute to proper folding and surface trafficking of the mature receptor molecule. Helical packing rearrangement within the seven‑transmembrane core constitutes the central mechanical event that permits cytoplasmic transducer coupling after extracellular ligand engagement.
Coding‑region variants mapping to FSHR leucine‑rich repeats or transmembrane helices may perturb ectodomain folding or helical‑bundle allostery, which could shift cellular responsiveness toward corresponding glycoprotein ligands within gonadal tissue model systems. Other glycoprotein‑binding GPCR members share partial architectural similarities, yet they cannot fully replicate FSHR’s ligand‑selection profile and gonadal‑biased expression pattern. FSHR requires lipid bilayer embedding to maintain full conformational competence; isolated soluble ectodomain fragments alone cannot transmit allosteric conformational signals across membrane boundaries. Its membrane‑embedded topology enables dual molecular roles: extracellular glycoprotein‑ligand sensing and allosteric relay of conformational signals toward cytoplasmic transducer assemblies. Diminished properly folded FSHR receptor populations at cell surfaces weaken the dynamic range of downstream signal propagation, making this gonadal GPCR a valuable research target for exploring glycoprotein‑triggered transmembrane signal transmission.
Fig. 1 Schematic topology diagram of human FSHR, depicting extracellular domain (ECD) composed of hormone‑binding domain (HBD) and hinge region, seven‑transmembrane domain (TMD) helical bundle, intracellular loops and C‑terminal cytoplasmic segment.1
The biological functions of integral‑membrane FSHR gonadal receptor focus on ectodomain‑mediated ligand capture and helical‑bundle‑driven cytoplasmic signal relay:
Creative Biolabs offers purified FSHR membrane protein samples produced under unified preparation workflows, including full‑length FSHR constructs and isolated leucine‑rich ectodomain variants. Truncated polypeptide fragments cannot support complete allosteric transmembrane signal relay activity, while full‑length forms suit gonadal GPCR‑oriented research. All batches receive uniform quality screening. Functional assessments may only be performed under simulated lipid bilayer microenvironment setups. Conserved leucine‑rich‑repeat and seven‑helix‑bundle structural features are preserved across batches to support comparative ligand‑interaction analysis between experimental groups. Full‑length FSHR membrane samples retain intact ligand‑recognition grooves and helical‑bundle allosteric surfaces post‑purification, supporting reliable detection of transient receptor‑ligand assemblies in comparative functional analysis.
Not finding the Membrane Protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides cell research models with adjustable FSHR expression levels, suitable for structural observation of glycoprotein‑sensing GPCR and gonadal signaling‑related studies. Sample assessment covers plasma‑membrane receptor population quantification and ligand‑interaction profiling, enabling side‑by‑side comparison of signaling responsiveness under varying FSHR abundances. These cell models can be paired with downstream cytoplasmic‑signal readout schemes to track response shifts linked to modified receptor dosage.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti FSHR recombinant antibodies are generated via standardized workflows, compatible with gonadal cell surface receptor localization mapping and receptor ligand complex identification. The antibody series supports multi dimensional observation of FSHR distribution within gonadal tissue samples.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for FSHR research:
FSHR may operate as a gonadal class‑A GPCR that recognizes circulating glycoprotein ligands and translates extracellular binding events into allosteric transmembrane conformational signals toward cytoplasmic transducers.
FSHR surface population and conformational competence might shape gonadal cellular responsiveness, serving as a key mediator of gonadal tissue signaling homeostasis biological processes.
No, all FSHR related products and services are strictly for research use only, and cannot be applied in clinical workflows. All material design and functional screening are optimized exclusively for basic laboratory research, without meeting clinical application criteria.
Offerings include full‑length FSHR membrane protein, target‑specific recombinant antibodies and tunable‑expression cell research models, supporting research on gonadal glycoprotein‑sensing transmembrane signaling.
Laboratory analysis schemes may include glycoprotein‑ligand co‑binding assays to evaluate receptor‑ligand complex formation capacity under simulated lipid bilayer environments.